Overview

Evaluation of [123I] MNI-187 and SPECT in Patients With Alzheimers Disease in Comparison to Healthy Subjects

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The underlying goal of this study is to assess 123-I MNI-187 SPECT imaging as a tool to detect ß-amyloid deposition in the brain of AD research participants and age- and gender-matched healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Institute for Neurodegenerative Disorders
Collaborator:
Molecular NeuroImaging